CXCR5 and prostate carcinoma: Recently, the CXCL13‐CXCR5 axis has been implicated in the progression of various tumours, including colon cancer,21 hepatocellular carcinoma,22 chronic lymphocytic leukaemia,23 breast cancer,23 neuroblastoma 24 and prostate cancer.25